Insulinoma

An insulinoma is a small, non-cancerous tumor in the pancreas. This tumor makes too much insulin. Too much insulin causes your blood sugar to drop very low, which is called hypoglycemia. This can make you feel very tired, shaky, confused, or even have seizures.

Condition

What people with Insulinoma report

Every report comes from a Lived member, sent anonymously.

Have you had Pancreatectomy for Insulinoma?

NameHow it went

About Insulinoma

What It Is

An insulinoma is a rare tumor in the pancreas that makes too much insulin. Insulin is the hormone that moves sugar (glucose) out of the blood and into the body's cells. Normally the pancreas cuts back on insulin as blood sugar falls. An insulinoma keeps releasing it anyway, so blood sugar can drop too low, a state called hypoglycemia. These lows usually happen when a person has gone a while without food, such as overnight or after a skipped or delayed meal, although some people also have episodes after eating. Early signs include sweating, shakiness, a pounding heart, anxiety and hunger. Because the brain runs on glucose, deeper lows can cause confusion, odd behavior, blurred vision, seizures or loss of consciousness. These episodes are sometimes mistaken for a psychiatric or neurological problem such as epilepsy, which can delay the diagnosis. Many people learn to eat often to head off symptoms, and weight gain is common. Most insulinomas are a single small tumor that is not cancer and has not spread. About 10% to 15% are an aggressive type that spreads beyond the pancreas, and that form is managed differently.

Causes & Risk Factors

Most insulinomas appear without any identifiable cause, and nothing a person did brought one on. They are diagnosed most often in middle age, slightly more often in women than in men. The clearest known risk factor is multiple endocrine neoplasia type 1 (MEN1), an inherited condition that causes tumors in several hormone-producing glands. Between 5% and 10% of insulinomas occur in people with MEN1, where they are more likely to be multiple and to appear at a younger age. Two other inherited conditions, neurofibromatosis type 1 and tuberous sclerosis complex, are also linked to insulinomas. Genetic testing is not routine for everyone with an insulinoma, but a doctor will ask about personal and family history and recommend testing when MEN1 seems possible. Some experts suggest considering it for anyone diagnosed at 35 or younger. Fasting, skipped meals and long gaps between meals do not cause the tumor. They reveal the low blood sugar it produces.

How It's Diagnosed

Diagnosis starts by proving that the symptoms really come from low blood sugar. Doctors look for three things together, known as Whipple's triad: symptoms of hypoglycemia, a low blood sugar measured at the time of those symptoms, and relief once blood sugar is brought back up. In people without diabetes, hypoglycemia generally means a blood sugar below 55 mg/dL (3.0 mmol/L). The telling finding is insulin that stays too high while blood sugar is low. Along with glucose, blood is tested for insulin, proinsulin (the form insulin is made from) and C-peptide, a fragment the pancreas releases in equal amounts with its own insulin. A high C-peptide shows the insulin is coming from the body rather than from an injection. Labs also check for diabetes pills that push the pancreas to release insulin, since they can cause the same pattern. If a low does not happen on its own, the standard test is a supervised fast in the hospital for up to 72 hours, with regular blood tests, so that samples can be taken if blood sugar falls. Only once blood tests confirm the problem do doctors search for the tumor. A CT scan usually comes first, followed by MRI or an endoscopic ultrasound, in which a thin scope passed through the mouth into the stomach images the pancreas from close by. About 30% of insulinomas are smaller than 1 centimeter, so they can be hard to find. A newer PET scan that targets the glucagon-like peptide 1 (GLP-1) receptor, a protein found on most noncancerous insulinoma cells, is highly sensitive for small tumors that other scans miss.

Treatment Options

Surgery to remove the tumor is the main treatment, and it cures most people with a single insulinoma that has not spread. When the tumor is small and sits a safe distance from the pancreas's main duct, the surgeon can often remove it on its own (enucleation), frequently with laparoscopic or robot-assisted keyhole surgery. A tumor in a harder position may require removing part of the pancreas. Surgery should be done once the diagnosis is certain and by a surgeon experienced in pancreatic operations. Possible complications include a leak of digestive fluid from the pancreas (a pancreatic fistula), bleeding and slow stomach emptying. Removing a larger part of the pancreas can leave someone needing digestive enzyme supplements or, rarely, insulin for diabetes. Before surgery, or when surgery is not possible, the priority is preventing lows. Regular meals and snacks with slowly digested carbohydrates, including one at bedtime, are the first step. A continuous glucose monitor, a small sensor worn on the skin that tracks sugar around the clock, can warn of lows, especially overnight. Diazoxide (Proglycem), a liquid medicine taken by mouth that reduces insulin release, usually works quickly. Fluid retention and swelling are common with it, so it is typically paired with a diuretic (water pill); palpitations, nausea, poor appetite and unwanted hair growth can also occur. Octreotide and lanreotide, injected medicines that mimic the hormone somatostatin and can block insulin release, help some people. They are started cautiously, because in some insulinomas they make lows worse. For someone who cannot have surgery or decides against it, radiofrequency ablation through an endoscope, which destroys the tumor with heat, is an option in selected cases, though long-term results are still being gathered. When an insulinoma has spread, surgery alone rarely cures it. Treatment then aims to control both the low blood sugar and the tumor's growth. Options include octreotide or lanreotide, surgery or other procedures to reduce tumor in the liver, the oral targeted cancer medicines everolimus and sunitinib, peptide receptor radionuclide therapy (a radioactive medicine that seeks out tumor cells) and chemotherapy. Everolimus has the useful side effect of raising blood sugar.

What to Expect

For most people, an insulinoma is a problem with a definite fix. Once a single noncancerous tumor is removed, the episodes of low blood sugar usually stop and the need to eat around the clock ends. Reported five-year survival for insulinoma that has not spread is 94% to 100%. Before treatment, daily life often revolves around avoiding lows: eating on a schedule, carrying food, and planning around sleep, work and activity. Family members or close friends who know the signs of a low can help, because confusion during an episode can make it hard to recognize one in yourself. After surgery, follow-up confirms that blood sugar stays normal. People with MEN1 need longer-term monitoring, because new tumors can develop over time. An insulinoma that has spread is a long-term condition managed with ongoing treatment, and outlook varies widely: reported five-year survival ranges from about 24% to 67%. For these people, keeping blood sugar safe remains part of daily life alongside cancer care.

When to Seek Help

See a doctor if you have repeated episodes of sweating, shakiness, confusion, unusual behavior or blurred vision that come on when you have gone without food and ease after eating, especially if you do not have diabetes. If you have been diagnosed, contact your care team promptly if lows become more frequent or harder to prevent, if they return after surgery, or if diazoxide causes noticeable swelling or rapid weight gain. During a low, eat or drink something containing sugar right away. A seizure or loss of consciousness from low blood sugar is an emergency: call 911.

Questions to Ask Your Doctor

  1. 1.How certain are we that my low blood sugar comes from an insulinoma rather than a medicine or another cause?
  2. 2.What did the scans show about the tumor's size and location, and does that make enucleation or a larger operation more likely?
  3. 3.Until surgery, how should I prevent and treat lows, and would a continuous glucose monitor or diazoxide help me?
  4. 4.Should I be tested for MEN1 or another inherited condition, and does my family need screening?
  5. 5.What follow-up will I need after treatment to make sure the low blood sugar does not come back?

Last reviewed • Oct 2026

Educational content, not medical advice.